Pluri Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLUR research report →
Range $12 – $12
Price Chart
About the company
Pluri Inc. , a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders.
- CEO
- Yaacov Yanay
- IPO
- 2003
- Employees
- 92
- HQ
- Haifa, HA, IL
Get TickerSpark's AI analysis on PLUR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $10.68M
- P/E
- -0.40
- PEG
- -0.01
- P/S
- 10.51
- P/B
- -0.47
- EV/EBITDA
- -1.75
- Div Yield
- 0.00%
- Gross Margin
- 44.59%
- Op Margin
- -2455.91%
- Net Margin
- -2406.00%
- ROE
- 144.63%
- ROIC
- -121.13%
Latest fiscal year · YoY change
- Revenue
- $1.02M-24.0%
- Gross Profit
- $453.00K-30.7%
- Op Income
- $-24,938,000
- Net Income
- $-23,821,000-5.5%
- EPS
- $-2.44+31.5%
- OCF Growth
- -7.6%
- FCF Growth
- -2.0%
- 52W High
- $4.87
- 52W Low
- $0.90
- 50D MA
- $1.40
- 200D MA
- $2.57
- Beta
- 0.69
- RSI (14)
- 33
- Avg Volume
- 26.19K
No earnings-call transcripts are available for PLUR yet.
- Free Float
- 57.2%
- Shares Outstanding
- 10.79M
- Float Shares
- 6.17M
of shares held by institutions
13 13F filers
Buy/sell ratio 3.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Renaissance Technologies LLC | 18.32K | ▼ 1.10K |
| Morgan Stanley | 2.98K | ▼ 94 |
| Eversource Wealth Advisors, LLC | 2.00K | 0 |
| Ubs Group AG | 1.92K | ▲ 1.82K |
| Sima Wealth Partners, LLC | 350 | 0 |
| Citigroup Inc | 191 | ▼ 1.17K |
| Wells Fargo & Company/Mn | 185 | 0 |
| Jpmorgan Chase & Co | 125 | 0 |
| Sbi Securities Co., Ltd. | 97 | 0 |
| Td Waterhouse Canada Inc. | 95 | ▲ 2 |
| Activest Wealth Management | 86 | ▲ 86 |
| Advisor Group Holdings, Inc. | 50 | 0 |
Held by 2 ETFs
Biggest fund positions in PLUR by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 20, 26 | SHORRER DORON | other | 31,569 |
| Aug 20, 26 | Manieu Alexandre Weinstein | other | 180,000 |
| Jun 19, 26 | SHORRER DORON | other | 0 |
| Jun 19, 26 | SHORRER DORON | other | 0 |
| Jun 30, 26 | Manieu Alexandre Weinstein | other | 641 |
| Jun 30, 26 | Manieu Alexandre Weinstein | other | 625,000 |
| Apr 21, 26 | Manieu Alexandre Weinstein | other | 312,500 |
| Apr 21, 26 | Manieu Alexandre Weinstein | other | 312,500 |
| Mar 31, 26 | Manieu Alexandre Weinstein | other | 312,500 |
| Mar 31, 26 | Manieu Alexandre Weinstein | other | 312,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PLUR coverage
Recent articles, reports, and earnings notes.
No research on PLUR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PLUR report →Pluri (PLUR) to Post Earnings on Wednesday
defenseworld.net · Sep 16
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor
globenewswire.com · Aug 27
Plurilock Security Inc. (PLUR:CA) Discusses Corporate Update and Growth Strategy in Defense Contracting Portfolio Transcript
seekingalpha.com · Aug 20
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment
globenewswire.com · Aug 17
Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK
globenewswire.com · Jul 28
Plurilock Announces Results of Annual General Meeting
newsfilecorp.com · Jun 16
Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing
globenewswire.com · Jun 2
Pluri Inc. (NASDAQ:PLUR) Sees Large Increase in Short Interest
defenseworld.net · Feb 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.